

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to peptidoglycan (GO:0032494) | 4.98738188 |
| 2 | negative regulation of interleukin-12 production (GO:0032695) | 4.86386054 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 4.50309502 |
| 4 | macrophage activation involved in immune response (GO:0002281) | 4.24653178 |
| 5 | glycosphingolipid catabolic process (GO:0046479) | 4.03124565 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.90816129 |
| 7 | amino sugar catabolic process (GO:0046348) | 3.89481818 |
| 8 | immunoglobulin mediated immune response (GO:0016064) | 3.87957100 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.87090258 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.87090258 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 3.87090258 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 3.87090258 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 3.87090258 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.87090258 |
| 15 | oligosaccharide catabolic process (GO:0009313) | 3.69869079 |
| 16 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.64607220 |
| 17 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.63229039 |
| 18 | negative regulation of cell killing (GO:0031342) | 3.63229039 |
| 19 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.62424161 |
| 20 | glycolipid catabolic process (GO:0019377) | 3.61516592 |
| 21 | detection of molecule of bacterial origin (GO:0032490) | 3.57380369 |
| 22 | regulation of mast cell degranulation (GO:0043304) | 3.52631357 |
| 23 | detection of other organism (GO:0098543) | 3.52375207 |
| 24 | regulation of mononuclear cell migration (GO:0071675) | 3.41594306 |
| 25 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.39285795 |
| 26 | cellular extravasation (GO:0045123) | 3.35903850 |
| 27 | detection of bacterium (GO:0016045) | 3.32488463 |
| 28 | detection of external biotic stimulus (GO:0098581) | 3.31868614 |
| 29 | T-helper 1 type immune response (GO:0042088) | 3.27301036 |
| 30 | ceramide catabolic process (GO:0046514) | 3.24518954 |
| 31 | regulation of leukocyte degranulation (GO:0043300) | 3.21654696 |
| 32 | granulocyte activation (GO:0036230) | 3.20662196 |
| 33 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.18797757 |
| 34 | germinal center formation (GO:0002467) | 3.16304047 |
| 35 | myeloid dendritic cell differentiation (GO:0043011) | 3.15577305 |
| 36 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.13805390 |
| 37 | positive regulation of mast cell activation (GO:0033005) | 3.12558136 |
| 38 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.12462763 |
| 39 | response to muramyl dipeptide (GO:0032495) | 3.11905161 |
| 40 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.10143159 |
| 41 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.09034885 |
| 42 | NIK/NF-kappaB signaling (GO:0038061) | 3.09020071 |
| 43 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.08272205 |
| 44 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.07194225 |
| 45 | macrophage activation (GO:0042116) | 3.06875964 |
| 46 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.06275535 |
| 47 | positive regulation of mast cell degranulation (GO:0043306) | 3.05179391 |
| 48 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.05179391 |
| 49 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.04757447 |
| 50 | positive regulation of antigen processing and presentation (GO:0002579) | 3.01915714 |
| 51 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.01284498 |
| 52 | myeloid cell activation involved in immune response (GO:0002275) | 2.99487564 |
| 53 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.98486717 |
| 54 | mannose metabolic process (GO:0006013) | 2.97915371 |
| 55 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.97022532 |
| 56 | regulation of gamma-delta T cell activation (GO:0046643) | 2.96431404 |
| 57 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.95982499 |
| 58 | response to thyroid hormone (GO:0097066) | 2.95977559 |
| 59 | detection of biotic stimulus (GO:0009595) | 2.92432809 |
| 60 | regulation of mast cell activation (GO:0033003) | 2.92334335 |
| 61 | positive regulation of leukocyte degranulation (GO:0043302) | 2.92312517 |
| 62 | regulation of antigen processing and presentation (GO:0002577) | 2.92006498 |
| 63 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.88325288 |
| 64 | cellular response to type I interferon (GO:0071357) | 2.87787612 |
| 65 | type I interferon signaling pathway (GO:0060337) | 2.87787612 |
| 66 | response to type I interferon (GO:0034340) | 2.86824800 |
| 67 | neutrophil activation (GO:0042119) | 2.86487818 |
| 68 | barbed-end actin filament capping (GO:0051016) | 2.86035033 |
| 69 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.85889064 |
| 70 | myeloid dendritic cell activation (GO:0001773) | 2.84440580 |
| 71 | respiratory burst (GO:0045730) | 2.83953267 |
| 72 | regulation of cholesterol storage (GO:0010885) | 2.81829298 |
| 73 | defense response to protozoan (GO:0042832) | 2.81767720 |
| 74 | response to protozoan (GO:0001562) | 2.81270674 |
| 75 | membrane lipid catabolic process (GO:0046466) | 2.80444302 |
| 76 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.80230131 |
| 77 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.79535215 |
| 78 | monocyte chemotaxis (GO:0002548) | 2.79397758 |
| 79 | N-acetylneuraminate metabolic process (GO:0006054) | 2.78514204 |
| 80 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.75959796 |
| 81 | positive regulation of type 2 immune response (GO:0002830) | 2.75677964 |
| 82 | regulation of interferon-alpha production (GO:0032647) | 2.75479477 |
| 83 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.74116641 |
| 84 | B cell mediated immunity (GO:0019724) | 2.72665516 |
| 85 | sphingolipid catabolic process (GO:0030149) | 2.72655001 |
| 86 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.69494436 |
| 87 | adhesion of symbiont to host cell (GO:0044650) | 2.69318582 |
| 88 | virion attachment to host cell (GO:0019062) | 2.69318582 |
| 89 | regulation of podosome assembly (GO:0071801) | 2.69244810 |
| 90 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.66149699 |
| 91 | neutrophil chemotaxis (GO:0030593) | 2.65232133 |
| 92 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.61323261 |
| 93 | pinocytosis (GO:0006907) | 2.60578206 |
| 94 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.60351280 |
| 95 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.59568402 |
| 96 | regulation of macrophage chemotaxis (GO:0010758) | 2.59532839 |
| 97 | response to host immune response (GO:0052572) | 2.59385296 |
| 98 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.59385296 |
| 99 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.58950945 |
| 100 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.58830348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.42686334 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.88128197 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.84209202 |
| 4 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.51645220 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.02995449 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.98789087 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.70310458 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.69079482 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.55008186 |
| 10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.51160626 |
| 11 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.40176276 |
| 12 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.30803245 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.24079507 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.23362856 |
| 15 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.15109276 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.13428143 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12634979 |
| 18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.11385581 |
| 19 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.05246992 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.05034600 |
| 21 | SPI1_23127762_ChIP-Seq_K562_Human | 2.04545846 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.03173624 |
| 23 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.97382972 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.87517887 |
| 25 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.81059228 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.76594055 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.73589119 |
| 28 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.73524819 |
| 29 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.72642454 |
| 30 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.70756746 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.70052253 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.69652086 |
| 33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.67316351 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.67206286 |
| 35 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.66195726 |
| 36 | MAF_26560356_Chip-Seq_TH1_Human | 1.66106106 |
| 37 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.65582419 |
| 38 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.64490477 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64011870 |
| 40 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.63266571 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.62994241 |
| 42 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.58372522 |
| 43 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.55704124 |
| 44 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.50028519 |
| 45 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.46585956 |
| 46 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.45244774 |
| 47 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.42764779 |
| 48 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39757680 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39227080 |
| 50 | UTX_26944678_Chip-Seq_JUKART_Human | 1.38398636 |
| 51 | MYC_22102868_ChIP-Seq_BL_Human | 1.38103836 |
| 52 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.37052904 |
| 53 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36659796 |
| 54 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36470398 |
| 55 | MAF_26560356_Chip-Seq_TH2_Human | 1.35259359 |
| 56 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32810700 |
| 57 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32069008 |
| 58 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.28370427 |
| 59 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.28231057 |
| 60 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.25210490 |
| 61 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23783353 |
| 62 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22888440 |
| 63 | KDM2B_26808549_Chip-Seq_K562_Human | 1.22275858 |
| 64 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21996164 |
| 65 | GATA1_19941826_ChIP-Seq_K562_Human | 1.21359779 |
| 66 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.20721305 |
| 67 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.20703300 |
| 68 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19966476 |
| 69 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.18749732 |
| 70 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.18408994 |
| 71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.16043651 |
| 72 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14650922 |
| 73 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.14188544 |
| 74 | P68_20966046_ChIP-Seq_HELA_Human | 1.13825092 |
| 75 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.12694751 |
| 76 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.12074667 |
| 77 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.11668496 |
| 78 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.11511029 |
| 79 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.10876250 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10528916 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08980641 |
| 82 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05963145 |
| 83 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.05855558 |
| 84 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.05733861 |
| 85 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04821028 |
| 86 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04592533 |
| 87 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.03883871 |
| 88 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01511922 |
| 89 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.01315564 |
| 90 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00815355 |
| 91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00565011 |
| 92 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00051609 |
| 93 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.99375780 |
| 94 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.98564345 |
| 95 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96669388 |
| 96 | GATA1_22025678_ChIP-Seq_K562_Human | 0.95857392 |
| 97 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.95541085 |
| 98 | MYB_26560356_Chip-Seq_TH2_Human | 0.95480650 |
| 99 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.93172390 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.93003424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.17300387 |
| 2 | MP0003303_peritoneal_inflammation | 4.12515373 |
| 3 | MP0003436_decreased_susceptibility_to | 3.43561585 |
| 4 | MP0003724_increased_susceptibility_to | 3.37453163 |
| 5 | MP0006082_CNS_inflammation | 3.20032983 |
| 6 | MP0009840_abnormal_foam_cell | 2.99260254 |
| 7 | MP0003172_abnormal_lysosome_physiology | 2.88298463 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.85549084 |
| 9 | MP0002419_abnormal_innate_immunity | 2.75634315 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.68558854 |
| 11 | MP0009785_altered_susceptibility_to | 2.66500926 |
| 12 | MP0004510_myositis | 2.52923704 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.45542086 |
| 14 | MP0005671_abnormal_response_to | 2.44035274 |
| 15 | MP0005387_immune_system_phenotype | 2.43924460 |
| 16 | MP0001790_abnormal_immune_system | 2.43924460 |
| 17 | MP0005025_abnormal_response_to | 2.39809001 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.35165504 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.32814348 |
| 20 | MP0000343_altered_response_to | 2.22189013 |
| 21 | MP0001533_abnormal_skeleton_physiology | 2.13310768 |
| 22 | MP0003075_altered_response_to | 2.04352709 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.02285160 |
| 24 | MP0000604_amyloidosis | 2.02067183 |
| 25 | MP0009278_abnormal_bone_marrow | 1.93905773 |
| 26 | MP0002723_abnormal_immune_serum | 1.93353338 |
| 27 | MP0002998_abnormal_bone_remodeling | 1.89990223 |
| 28 | MP0000685_abnormal_immune_system | 1.89491065 |
| 29 | MP0005451_abnormal_body_composition | 1.87701595 |
| 30 | MP0001800_abnormal_humoral_immune | 1.85149039 |
| 31 | MP0002139_abnormal_hepatobiliary_system | 1.75979867 |
| 32 | MP0002254_reproductive_system_inflammat | 1.75624526 |
| 33 | MP0009764_decreased_sensitivity_to | 1.74675701 |
| 34 | MP0001819_abnormal_immune_cell | 1.70888728 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.70362106 |
| 36 | MP0004947_skin_inflammation | 1.68438544 |
| 37 | MP0003806_abnormal_nucleotide_metabolis | 1.68097687 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.60785328 |
| 39 | MP0002405_respiratory_system_inflammati | 1.57107201 |
| 40 | MP0001853_heart_inflammation | 1.53615420 |
| 41 | MP0008469_abnormal_protein_level | 1.51220775 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.49320100 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.48442756 |
| 44 | MP0003453_abnormal_keratinocyte_physiol | 1.47829142 |
| 45 | MP0003690_abnormal_glial_cell | 1.46655073 |
| 46 | MP0008004_abnormal_stomach_pH | 1.45275548 |
| 47 | MP0005310_abnormal_salivary_gland | 1.42498294 |
| 48 | MP0000858_altered_metastatic_potential | 1.41504825 |
| 49 | MP0003828_pulmonary_edema | 1.41366504 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.37086536 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.37086536 |
| 52 | MP0005167_abnormal_blood-brain_barrier | 1.36539533 |
| 53 | MP0003448_altered_tumor_morphology | 1.35987809 |
| 54 | MP0008260_abnormal_autophagy | 1.34928390 |
| 55 | MP0003279_aneurysm | 1.27032272 |
| 56 | MP0005166_decreased_susceptibility_to | 1.25311916 |
| 57 | MP0009333_abnormal_splenocyte_physiolog | 1.23315713 |
| 58 | MP0000716_abnormal_immune_system | 1.15659638 |
| 59 | MP0003329_amyloid_beta_deposits | 1.08810479 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.06995094 |
| 61 | MP0002933_joint_inflammation | 1.06821252 |
| 62 | MP0005390_skeleton_phenotype | 1.05705966 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 1.03262109 |
| 64 | MP0005164_abnormal_response_to | 1.02490311 |
| 65 | MP0004883_abnormal_blood_vessel | 0.95838838 |
| 66 | MP0002138_abnormal_hepatobiliary_system | 0.94077022 |
| 67 | MP0001849_ear_inflammation | 0.93206960 |
| 68 | MP0006054_spinal_hemorrhage | 0.92538014 |
| 69 | MP0003195_calcinosis | 0.90783119 |
| 70 | MP0002398_abnormal_bone_marrow | 0.90530017 |
| 71 | MP0003091_abnormal_cell_migration | 0.89896259 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 0.89515344 |
| 73 | MP0000920_abnormal_myelination | 0.88006507 |
| 74 | MP0005165_increased_susceptibility_to | 0.87923611 |
| 75 | MP0003795_abnormal_bone_structure | 0.87874689 |
| 76 | MP0002429_abnormal_blood_cell | 0.87508643 |
| 77 | MP0005023_abnormal_wound_healing | 0.86248827 |
| 78 | MP0005365_abnormal_bile_salt | 0.85420958 |
| 79 | MP0001542_abnormal_bone_strength | 0.84923482 |
| 80 | MP0000249_abnormal_blood_vessel | 0.81742754 |
| 81 | MP0000689_abnormal_spleen_morphology | 0.81292913 |
| 82 | MP0002277_abnormal_respiratory_mucosa | 0.80026460 |
| 83 | MP0001851_eye_inflammation | 0.79733870 |
| 84 | MP0001958_emphysema | 0.77924417 |
| 85 | MP0000465_gastrointestinal_hemorrhage | 0.77603401 |
| 86 | MP0001663_abnormal_digestive_system | 0.77020121 |
| 87 | MP0009763_increased_sensitivity_to | 0.77002387 |
| 88 | MP0002722_abnormal_immune_system | 0.73037494 |
| 89 | MP0005076_abnormal_cell_differentiation | 0.72511207 |
| 90 | MP0000767_abnormal_smooth_muscle | 0.72337034 |
| 91 | MP0005595_abnormal_vascular_smooth | 0.69697232 |
| 92 | MP0000371_diluted_coat_color | 0.67080928 |
| 93 | MP0002332_abnormal_exercise_endurance | 0.67002439 |
| 94 | MP0008874_decreased_physiological_sensi | 0.65998774 |
| 95 | MP0005319_abnormal_enzyme/_coenzyme | 0.63119973 |
| 96 | MP0005647_abnormal_sex_gland | 0.62819170 |
| 97 | MP0002877_abnormal_melanocyte_morpholog | 0.62292848 |
| 98 | MP0001873_stomach_inflammation | 0.61458268 |
| 99 | MP0003763_abnormal_thymus_physiology | 0.60376552 |
| 100 | MP0005257_abnormal_intraocular_pressure | 0.58493068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 6.95737557 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.95737557 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.95737557 |
| 4 | Abnormality of macrophages (HP:0004311) | 5.00855701 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 4.85751867 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.80446294 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 4.73397221 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 4.63871674 |
| 9 | Dysostosis multiplex (HP:0000943) | 4.55400895 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 4.26863003 |
| 11 | Recurrent abscess formation (HP:0002722) | 4.23532984 |
| 12 | Loss of speech (HP:0002371) | 4.13979064 |
| 13 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.99092953 |
| 14 | Myositis (HP:0100614) | 3.89788287 |
| 15 | Orchitis (HP:0100796) | 3.88610893 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.78454856 |
| 17 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.73817356 |
| 18 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.73817356 |
| 19 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.73817356 |
| 20 | Optic neuritis (HP:0100653) | 3.68179877 |
| 21 | Retrobulbar optic neuritis (HP:0100654) | 3.68179877 |
| 22 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.53254389 |
| 23 | Mucopolysacchariduria (HP:0008155) | 3.53254389 |
| 24 | Disinhibition (HP:0000734) | 3.47610604 |
| 25 | Axonal loss (HP:0003447) | 3.44223024 |
| 26 | Nuclear cataract (HP:0100018) | 3.33778285 |
| 27 | Mediastinal lymphadenopathy (HP:0100721) | 3.26474982 |
| 28 | Neurofibrillary tangles (HP:0002185) | 2.95332898 |
| 29 | Mutism (HP:0002300) | 2.94279979 |
| 30 | Glomerulonephritis (HP:0000099) | 2.90144669 |
| 31 | Stomatitis (HP:0010280) | 2.78558864 |
| 32 | Autoimmune thrombocytopenia (HP:0001973) | 2.74771669 |
| 33 | Chronic obstructive pulmonary disease (HP:0006510) | 2.73863726 |
| 34 | Obstructive lung disease (HP:0006536) | 2.73863726 |
| 35 | Purpura (HP:0000979) | 2.73153771 |
| 36 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.72971076 |
| 37 | Myocardial infarction (HP:0001658) | 2.70162560 |
| 38 | Gingivitis (HP:0000230) | 2.68762340 |
| 39 | Amyloidosis (HP:0011034) | 2.65733439 |
| 40 | Hepatosplenomegaly (HP:0001433) | 2.65612490 |
| 41 | Recurrent skin infections (HP:0001581) | 2.64225322 |
| 42 | Pulmonary infiltrates (HP:0002113) | 2.52368531 |
| 43 | Keratoconjunctivitis sicca (HP:0001097) | 2.52191980 |
| 44 | Spontaneous hematomas (HP:0007420) | 2.50834598 |
| 45 | Hemoptysis (HP:0002105) | 2.49147958 |
| 46 | Increased serum ferritin (HP:0003281) | 2.47919222 |
| 47 | Recurrent fungal infections (HP:0002841) | 2.44290794 |
| 48 | Thin bony cortex (HP:0002753) | 2.38322310 |
| 49 | Progressive neurologic deterioration (HP:0002344) | 2.35295152 |
| 50 | Neuronal loss in central nervous system (HP:0002529) | 2.34529902 |
| 51 | Hematochezia (HP:0002573) | 2.34175988 |
| 52 | Asymmetric septal hypertrophy (HP:0001670) | 2.34142462 |
| 53 | Complement deficiency (HP:0004431) | 2.32284689 |
| 54 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.31235272 |
| 55 | Keratoconjunctivitis (HP:0001096) | 2.29076133 |
| 56 | Upper motor neuron abnormality (HP:0002127) | 2.23413826 |
| 57 | Interstitial pulmonary disease (HP:0006530) | 2.22651831 |
| 58 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.22642191 |
| 59 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.22499075 |
| 60 | Malnutrition (HP:0004395) | 2.20360803 |
| 61 | Meningitis (HP:0001287) | 2.20132111 |
| 62 | Diminished motivation (HP:0000745) | 2.18647195 |
| 63 | Cerebral inclusion bodies (HP:0100314) | 2.18312152 |
| 64 | Apathy (HP:0000741) | 2.17015822 |
| 65 | Petechiae (HP:0000967) | 2.15976769 |
| 66 | Vasculitis (HP:0002633) | 2.15892629 |
| 67 | Pathologic fracture (HP:0002756) | 2.13518837 |
| 68 | Abnormality of complement system (HP:0005339) | 2.11448944 |
| 69 | J-shaped sella turcica (HP:0002680) | 2.08466111 |
| 70 | Joint stiffness (HP:0001387) | 2.05932658 |
| 71 | Premature loss of primary teeth (HP:0006323) | 2.05232777 |
| 72 | Increased IgE level (HP:0003212) | 2.02946875 |
| 73 | Cellulitis (HP:0100658) | 2.02065807 |
| 74 | Gastrointestinal infarctions (HP:0005244) | 2.01546880 |
| 75 | Abnormality of the nasal mucosa (HP:0000433) | 2.01422920 |
| 76 | Recurrent cutaneous fungal infections (HP:0011370) | 1.98322292 |
| 77 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.98322292 |
| 78 | Metaphyseal irregularity (HP:0003025) | 1.98305481 |
| 79 | Abnormality of iron homeostasis (HP:0011031) | 1.96843653 |
| 80 | Polyneuropathy (HP:0001271) | 1.96385663 |
| 81 | Dementia (HP:0000726) | 1.95481858 |
| 82 | Bone pain (HP:0002653) | 1.94917302 |
| 83 | Urticaria (HP:0001025) | 1.93635454 |
| 84 | Vertebral compression fractures (HP:0002953) | 1.85457602 |
| 85 | Cervical subluxation (HP:0003308) | 1.85434834 |
| 86 | Basal ganglia calcification (HP:0002135) | 1.85360389 |
| 87 | Restrictive lung disease (HP:0002091) | 1.83789782 |
| 88 | Encephalitis (HP:0002383) | 1.83040332 |
| 89 | Personality changes (HP:0000751) | 1.81906899 |
| 90 | Thoracic kyphosis (HP:0002942) | 1.81330591 |
| 91 | Agnosia (HP:0010524) | 1.81195840 |
| 92 | Prolonged neonatal jaundice (HP:0006579) | 1.81136955 |
| 93 | Pulmonary embolism (HP:0002204) | 1.80945075 |
| 94 | Abnormality of the periventricular white matter (HP:0002518) | 1.77089751 |
| 95 | Nephritis (HP:0000123) | 1.76178317 |
| 96 | Colitis (HP:0002583) | 1.76147571 |
| 97 | Arterial thrombosis (HP:0004420) | 1.75911527 |
| 98 | Acne (HP:0001061) | 1.75213636 |
| 99 | Gangrene (HP:0100758) | 1.74230355 |
| 100 | Global brain atrophy (HP:0002283) | 1.74057393 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 3.06603774 |
| 2 | RIPK4 | 2.97409997 |
| 3 | IRAK3 | 2.89771691 |
| 4 | ERN1 | 2.75253649 |
| 5 | MAP3K14 | 2.51062325 |
| 6 | NME2 | 2.48186223 |
| 7 | MAP4K1 | 2.47900415 |
| 8 | TBK1 | 2.37744249 |
| 9 | MAP2K3 | 2.29153129 |
| 10 | CSK | 2.27818029 |
| 11 | TYK2 | 2.27238332 |
| 12 | TGFBR2 | 2.22865553 |
| 13 | IRAK4 | 2.14746638 |
| 14 | MAP3K11 | 2.11032722 |
| 15 | GRK7 | 1.98487897 |
| 16 | MAP3K3 | 1.95298656 |
| 17 | TAOK1 | 1.95207009 |
| 18 | ZAP70 | 1.95032260 |
| 19 | PRPF4B | 1.94596941 |
| 20 | DDR2 | 1.83791788 |
| 21 | TAOK2 | 1.82406660 |
| 22 | RIPK1 | 1.79272646 |
| 23 | MAP3K13 | 1.79147798 |
| 24 | FGR | 1.77889048 |
| 25 | MATK | 1.77174311 |
| 26 | CDC42BPA | 1.64488893 |
| 27 | SIK1 | 1.60620511 |
| 28 | TRIB3 | 1.57457766 |
| 29 | TNK2 | 1.46432511 |
| 30 | IKBKB | 1.45858764 |
| 31 | JAK3 | 1.45610041 |
| 32 | IKBKE | 1.41808458 |
| 33 | TXK | 1.38584270 |
| 34 | FES | 1.32913598 |
| 35 | MAP3K1 | 1.25168702 |
| 36 | EPHB1 | 1.23480848 |
| 37 | CSF1R | 1.13606738 |
| 38 | MAPK15 | 1.09908379 |
| 39 | SYK | 1.08455935 |
| 40 | MOS | 1.05919307 |
| 41 | TESK1 | 1.04316065 |
| 42 | HCK | 1.03570920 |
| 43 | ABL2 | 1.03296086 |
| 44 | KIT | 1.03109161 |
| 45 | LYN | 1.02581743 |
| 46 | TESK2 | 1.01539006 |
| 47 | MAP2K6 | 1.01331814 |
| 48 | JAK1 | 0.97716620 |
| 49 | MARK2 | 0.96457040 |
| 50 | PRKD2 | 0.96218361 |
| 51 | IRAK2 | 0.93731907 |
| 52 | PIM2 | 0.92461286 |
| 53 | MAP3K6 | 0.92398071 |
| 54 | BTK | 0.91985786 |
| 55 | CHUK | 0.87939597 |
| 56 | JAK2 | 0.87732414 |
| 57 | SIK3 | 0.86559156 |
| 58 | KDR | 0.84163279 |
| 59 | LCK | 0.81168865 |
| 60 | CAMK1D | 0.78766831 |
| 61 | PDPK1 | 0.77528957 |
| 62 | MAPK7 | 0.76960949 |
| 63 | TTN | 0.76664486 |
| 64 | RPS6KA2 | 0.76289021 |
| 65 | GRK6 | 0.75989317 |
| 66 | PAK4 | 0.75644075 |
| 67 | RPS6KC1 | 0.75101181 |
| 68 | RPS6KL1 | 0.75101181 |
| 69 | MAPK12 | 0.71015892 |
| 70 | NEK9 | 0.67559882 |
| 71 | MARK3 | 0.67518535 |
| 72 | IRAK1 | 0.64301250 |
| 73 | RPS6KA6 | 0.61610733 |
| 74 | EPHA3 | 0.61499303 |
| 75 | PTK6 | 0.60829563 |
| 76 | BMX | 0.60446019 |
| 77 | CAMKK2 | 0.59226015 |
| 78 | ARAF | 0.58812397 |
| 79 | PDK1 | 0.56924802 |
| 80 | ADRBK2 | 0.55774210 |
| 81 | PRKG2 | 0.54714631 |
| 82 | MAP3K5 | 0.53967107 |
| 83 | ACVR1B | 0.53191965 |
| 84 | KSR2 | 0.49784665 |
| 85 | DAPK2 | 0.49403979 |
| 86 | HIPK2 | 0.47165921 |
| 87 | MAPK4 | 0.45130369 |
| 88 | FGFR4 | 0.44182721 |
| 89 | PDGFRB | 0.43206492 |
| 90 | PDGFRA | 0.42433934 |
| 91 | BMPR2 | 0.42012779 |
| 92 | ITK | 0.39667072 |
| 93 | SIK2 | 0.39244934 |
| 94 | ICK | 0.36681267 |
| 95 | FYN | 0.35619415 |
| 96 | MAPKAPK2 | 0.35180447 |
| 97 | STK10 | 0.32955444 |
| 98 | ABL1 | 0.32534126 |
| 99 | PRKD1 | 0.30870275 |
| 100 | MAPKAPK3 | 0.30843264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.90384826 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.06116933 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 3.03125774 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.80830353 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.62085346 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.61911860 |
| 7 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.40410951 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.31026793 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.18201795 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.16725161 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 2.13626329 |
| 12 | Malaria_Homo sapiens_hsa05144 | 2.01723814 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.99544353 |
| 14 | Asthma_Homo sapiens_hsa05310 | 1.97361519 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.89278167 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.85619688 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 1.84143147 |
| 18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.77803062 |
| 19 | Phagosome_Homo sapiens_hsa04145 | 1.69968719 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.68629846 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.68549285 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.66468595 |
| 23 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.62891153 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.55248692 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.54938488 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53856716 |
| 27 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.47654347 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.43021340 |
| 29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42928157 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.42373347 |
| 31 | Salmonella infection_Homo sapiens_hsa05132 | 1.41407170 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.40634547 |
| 33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.38724684 |
| 34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.37511249 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.32811247 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.25882071 |
| 37 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.20464373 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14818934 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14405467 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.13278750 |
| 41 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.10854315 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.05722156 |
| 43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.03677240 |
| 44 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.03308737 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 1.00566146 |
| 46 | Prion diseases_Homo sapiens_hsa05020 | 1.00251385 |
| 47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.00132472 |
| 48 | Amoebiasis_Homo sapiens_hsa05146 | 0.98019693 |
| 49 | Measles_Homo sapiens_hsa05162 | 0.96699358 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.93805975 |
| 51 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.91287383 |
| 52 | Shigellosis_Homo sapiens_hsa05131 | 0.89525569 |
| 53 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.88728466 |
| 54 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.87964323 |
| 55 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84843523 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.83281838 |
| 57 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.83203630 |
| 58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.82896877 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82294571 |
| 60 | Bladder cancer_Homo sapiens_hsa05219 | 0.79180283 |
| 61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77794313 |
| 62 | Apoptosis_Homo sapiens_hsa04210 | 0.77522391 |
| 63 | Hepatitis B_Homo sapiens_hsa05161 | 0.77419744 |
| 64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.76879597 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.72579478 |
| 66 | Galactose metabolism_Homo sapiens_hsa00052 | 0.69482200 |
| 67 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.66784310 |
| 68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62325386 |
| 69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61174460 |
| 70 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.60666321 |
| 71 | Mineral absorption_Homo sapiens_hsa04978 | 0.60193452 |
| 72 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.59691014 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.57205951 |
| 74 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56054706 |
| 75 | Platelet activation_Homo sapiens_hsa04611 | 0.54693324 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54279867 |
| 77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49832700 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48785868 |
| 79 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46783767 |
| 80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44497019 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44487075 |
| 82 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.41153422 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.39550700 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39519158 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33687999 |
| 86 | HTLV-I infection_Homo sapiens_hsa05166 | 0.32228366 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32208739 |
| 88 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.31899367 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28955271 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.27863140 |
| 91 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.27064550 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24501365 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24337903 |
| 94 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.23300868 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.23256224 |
| 96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.22450250 |
| 97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.22221221 |
| 98 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.22018427 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.21716824 |
| 100 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.21346091 |

